Synthetic Biology in the Pharma Industry- An Interview with Professor James Collins
As part of our Future Pharma series, Pharma IQ is examining the promise held by synthetic biology. Our editor spoke to Professor James Collins, Professor of Biomedical Engineering at Boston University and founding faculty member at the Weiss Institute at Harvard University. Professor Collins describes being on the ground floor of the creation of a field which is set to reshape many industries, including pharmaceuticals.
Have Your Say
Rate this feature and gi...
To continue reading this story
Please note: That all fields marked with an asterisk (*) are required.